EBioMedicine

EBioMedicine is a peer-reviewed open access medical journal covering all areas of preclinical and clinical research. The journal was established in 2014 and is published by Elsevier on behalf of The Lancet.

Overview

EBioMedicine aims to bridge the gap between basic research and clinical practice. It publishes research papers that are relevant to human health and disease, as well as reviews and commentaries. The journal covers a wide range of medical disciplines, including oncology, neuroscience, cardiology, metabolism, infectious diseases, and immunology.

Publication Model

As an open access journal, all articles in EBioMedicine are freely available to read, download, and share. The journal operates under the gold open access model, which means that the authors of accepted papers are required to pay an article processing charge to cover the costs of publication. In return, their work is immediately freely available to the global community.

Indexing and Abstracting

EBioMedicine is indexed and abstracted in major databases such as PubMed, Scopus, and the Science Citation Index Expanded. This ensures that the research published in the journal is easily discoverable and accessible to researchers around the world.

Editorial Process

The editorial process at EBioMedicine involves a rigorous peer review to ensure the quality and integrity of the research. The journal employs a team of in-house editors, as well as an international editorial board of experts in various medical disciplines.

Impact

EBioMedicine has a high impact factor, indicating that the research published in the journal is frequently cited in the scientific literature. This reflects the journal's commitment to publishing high-quality, impactful research that advances our understanding of human health and disease.